Insight Molecular Diagnostics (IMDX) Revenue (2020 - 2026)

Insight Molecular Diagnostics has disclosed Revenue across 7 years of filings, most recently posting $32000.0 for Q1 2026.

• Revenue for Q1 2026 came in at $32000.0, down 98.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (down 49.28% YoY), and the FY2025 annual result was $4.1 million, up 115.58% from the prior year.
• Revenue came in at $32000.0 for Q1 2026 at Insight Molecular Diagnostics, down from $1.1 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $2.1 million in Q1 2025 to a low of $32000.0 in Q1 2026.
• The 5-year median for Revenue is $297000.0 (2023), against an average of $495823.5.
• Across the five-year window, Revenue surged 1114.77% in 2025 and sank 98.5% in 2026, its largest moves.
• Insight Molecular Diagnostics' Revenue stood at $274000.0 in 2022, then advanced by 14.6% to $314000.0 in 2023, then soared by 373.25% to $1.5 million in 2024, then dropped by 23.35% to $1.1 million in 2025, then tumbled by 97.19% to $32000.0 in 2026.
• The last three Revenue figures came in at $32000.0 (Q1 2026), $1.1 million (Q4 2025), and $260000.0 (Q3 2025), per Business Quant data.